[1]EuropeanJournalofMedicinalChemistry,2014,vol.84,p.312-334
[1]Patent:US2017/275290,2017,A1.Locationinpatent:Paragraph0841;0842
1020719-52-1
1020719-24-7
77837-09-3
77837-08-2
887406-49-7
89960-36-1
871713-60-9 | N-(4-Bromothiophen-2-ylmethyl) phthalimide | AA00IEBQ | MFCD11040394
874804-00-9 | 2-[2-(Trifluoromethyl)phenoxy]acetohydrazide | AA00IEJP | MFCD06409074
879486-47-2 | N-(morpholin-4-yl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | AA00IERA | MFCD20527096
88511-13-1 | (1,1-Dioxido-3-thietanyl)amine | AA00IF1N | MFCD11847691
886496-45-3 | 4-bromo-1-fluoro-2-(trifluoromethoxy)benzene | AA00IF7P | MFCD06660160
889672-72-4 | 2-Chlorothiazole-5-boronic acid pinacol ester | AA00IFG5 | MFCD29059788
894797-00-3 | 5-Chloropyrimidine-2-carboxylic acid methyl ester | AA00IFO0 | MFCD16611603
899899-20-8 | 1-(2-Methoxyethyl)-1h-pyrazol-3-amine | AA00IFUX | MFCD09965616
90326-62-8 | Methyl 3-bromo-4-(hydroxymethyl)benzoate | AA00IG0V | MFCD15527253
908571-75-5 | (S)-2-Amino-3-(3-aminophenyl)propanoic acid dihydrochloride | AA00IG8J | MFCD29919675